Idiopathic pulmonary fibrosis is a progressive disease with unsatisfactory systemic treatments. Aerosol drug delivery to the lungs is expected to be an interesting route of administration. However, due to the alterations of lung compliance caused by fibrosis, local delivery remains challenging. This work aimed to develop a practical, relevant and ethically less restricted ex vivo respiratory model of fibrotic lung for regional aerosol deposition studies. This model is composed of an Ear-Nose-Throat replica connected to a sealed enclosure containing an ex vivo porcine respiratory tract, which was modified to mimic the mechanical properties of fibrotic lung parenchyma -i.e. reduced compliance. Passive respiratory mechanics were measured. 81m Kr scintigraphies were used to assess the homogeneity of gas-ventilation, while regional aerosol deposition was assessed with 99m Tc-DTPA scintigraphies. We validated the procedure to induce modifications of lung parenchyma to obtain aimed variation of compliance. Compared to the healthy model, lung respiratory mechanics were modified to the same extent as IPF-suffering patients. 81m Kr gas-ventilation and 99m tc-DtpA regional aerosol deposition showed results comparable to clinical studies, qualitatively. This ex vivo respiratory model could simulate lung fibrosis for aerosol regional deposition studies giving an interesting alternative to animal experiments, accelerating and facilitating preclinical studies before clinical trials.
Results and Discussion
Performance analysis of physical methods to reduce lung compliance mimicking the mechanical behavior of a fibrotic lung. These experiments aimed to find a reliable and reproducible method to simulate lung fibrosis on ex vivo porcine respiratory tracts ( Fig. 1 and Tables S1 and S2 the Supplementary Information). Figure 1 presents the resistances and the dynamic compliance of the respiratory tract expressed as mean ± standard deviation of the relative value of the "healthy" stage of the lungs (i.e. lungs with no modification). Resistances (R) with glue (G) method appeared to be uneven with important dispersion of data. Inversely, steam (S) method showed a much narrower dispersion and a slight modification of R when compared to the healthy stage. However, when reaching stage 4 (i.e. methods applied to whole lungs) with S method we observed an important increase of the standard deviation showing a lack of reproducibility for this specific stage (see Supplementary Information). Glue + steam (GS) method suffered from a wide dispersion of data as G method (Fig. 1A) . Dynamic compliance of lung decreased with the incrementing stages of the three methods. The strongest variations of compliance were seen with G and GS method. S method induced a less important reduction of compliance ( Fig. 1B) .
Considering the presented results, G and GS methods were generating barely reproducible data, while S method was more reproducible and repeatable. One hypothesis explaining the differences between G and S methods is that G method is more likely to simulate a pleural disease while the thermal treatment of the S method is more likely to simulate "fibrotic lung pattern" by denaturing extracellular matrix proteins [46] [47] [48] . Moreover, applying the S method on lung parenchyma induced a visual shrinking of the treated regions. However, we did not assess that this thermal treatment had any significant impact of the small airways, which exert a relative widening in parenchymal regions suffering from IPF 19, 21 . Thus, careful extrapolation should be made for this point, which should not impact the validity of aerosol deposition pattern. Therefore, we decided to select the S method as the more relevant method to generate modifications of lung parenchyma leading to impaired mechanical properties of the lung needed to simulate the decreased lung compliance observed in IPF. Lastly, as the aim of this study was to simulate a moderate IPF, it was decided to focus on stage 3 (i.e. physical method applied to entire upper lobes + bases of lower lobes). Indeed, this stage induces a slight modification of resistances for an important modification of compliance (Figs. S2-S4 in Supplementary Information). The selected method did not include mucus accumulation in the airways, which is an uncommon feature of IPF. Moreover, even if we were unable to precisely assess the mucus status in the broncho-alveolar regions, we could assume that mucus is present and could be accumulated in these regions as observed in IPF-suffering patients 3 .
ues and 95% confidence interval of experimental data collected for the 30 ex vivo respiratory models. As expected, inspiratory time (IT), expiratory time (ET) and respiratory rates (RR) are very close from aimed values meaning that the developed respiratory model is tunable at will and reliable for these RR. Reliability and reproducibility data are presented in Tables S3 and S4 in the Supplementary Information. For "healthy" lungs, two RR were tested: 15 and 25 cycles/min. For "fibrotic" lungs, only 25 cycles/min was used. Fifteen cycles per minute was used as RR for healthy lungs in accordance with our previous data used to validate the "healthy" ex vivo respiratory model 41, 42, 49 . The RR of 25 cycles per minute was chosen to mimic IPF. These RR are similar to those found for healthy adult subjects and IPF-suffering adult patients 8, 10, 12 . According to experimental data and predefined thresholds -i.e. inter-individual variations about 30% and intra-individual variations about 15% -we assumed the reliability and the reproducibility of our model.
The healthy ex vivo respiratory model. Before application of S, tidal volume (TV) was 515.2 ± 77.0 mL and minute-ventilation (MV) was 7.86 ± 1.11 L/min. Mean inspiratory flow (MIF) was 361.4 ± 39.3 mL/s. Lastly, R values were 13.23 ± 3.41 cmH 2 O/(L/s), while dynamic compliance (C) values were 90.44 ± 27.97 mL/cmH 2 O. Observed results are consistent with previously published data concerning the healthy ex vivo respiratory model 41, 49 and in good accordance with data available in the literature from in vivo studies on healthy subjects 10 . MIF values appear to be similar to values obtained of healthy subjects as showed Renzi et al. 10 . Lastly, experimental C values, 90.44 ± 27.97 mL/cmH 2 O, are almost 2 times lower than commonly considered as normal for healthy lobes + entire lower lobes. "G healthy" (respectively the "S healthy" and the "GS healthy") corresponds to the lungs before modifications which will be induced at different stages by the G method (respectively the S method and the GS method). Data are presented as median and inter-quartile range of the relative value of the healthy stage of the corresponding method. ***Corresponds to p < 0.0001 when compared to glue method. ## and ### corresponds to p < 0.001 and p < 0.0001 respectively when compared to steam method. ns corresponds to nonsignificant.
subjects. The relatively low values obtained with our model were most probably due to the lack of perfusion and the unknown status of surfactant.
The fibrotic ex vivo respiratory model. We applied the S method to the lungs to reduce lung compliance by modifying the mechanical properties of lungs parenchyma. We also modified the RR, which was set at 25, to better simulate the breathing pattern of an IPF-suffering patient. TV was 259.4 ± 48.8 mL while MV was 6.62 ± 1.10 L/ min. Results found in literature showed that TV of IPF-suffering patient is around 400mL 8, 10, 12 , which is higher than the developed model. R and C values were respectively 10.54 ± 1. Physiological reliability of the respiratory ex vivo model. To sum up, all the 5 respiratory features assessed were found to be in the same order of magnitude as in vivo data for adult suffering of IPF and with previously obtained results on "healthy" ex vivo model. However, features by features, we observed that some results were different than expected values. Nevertheless, differences observed between our experimental data -particularly the low TV for the IPF model -and those obtained from literature could be due to patients' ability to increase muscle workload during inspiration and expiration to compensate lung stiffness, while we only applied fixed negative pressures. To compensate this phenomenon, we are currently developing a new depression generator allowing to tune the applied negative pressure in the enclosure. Moreover, some limitations of the ex vivo model could impact these respiratory physiological features as the lack of lung surfactant and the absence of blood perfusion. Indeed, surfactant is responsible for approximately 50% of compliance of the system 50 . Perfusion of lungs is also an important parameter related to resistances. Assessment of regional gas-ventilation by 81m Kr scintigraphies. Figure 2 presents scintigraphic images of 81m Kr gas-ventilation. Scintigraphic measurements of ventilation using 81m Kr were made on 12 lungs whose compliance was modified with the S method at stage 3 (i.e. physical method applied to entire upper lobes + bases of lower lobes). Due to the very short half-life of 81m Kr, repartition of this gas within lungs is widely considered to allow imaging of regional gas-ventilation 51 . Experiments showed a symmetry in left/right regional gas-ventilation with 50.10% ± 3.60% in the left lung and 49.91% ± 3.60 in the right lung. When compared to the previously developed healthy ex vivo model 41, 49 , there was no significant differences in terms of left/right regional gas-ventilation (Table 2, Fig. 2 and Figs. S5 and S6 in Supplementary Information). However, when taking into account the central-to-peripheral ratio, we observed that the penetration index of 81m Kr gas in our IPF model, 53.10 ± 1.98%, is lower compared to the data observed on the previous healthy ex vivo model, which exerted a central-to-peripheral ratio about 62.56% 41 (p < 0.0001). However, literature lacks of quantitative data because 81m Kr ventilation scintigraphies are usually coupled with 99m Tc-albumin scintigraphy, to assess the qualitative ventilation/perfusion mismatch. Hence, comparison with available in vivo data was only qualitative. This gas-ventilation homogeneity is in good accordance with in vivo data obtained from patients suffering of IPF [14] [15] [16] 20, 44, 52 .
Regional aerosol deposition. Healthy versus fibrotic ex vivo respiratory model: impact of the alteration of
lung compliance on the aerosol regional deposition. The regional aerosol deposition was recorded by planar scintigraphies using gamma-camera imaging (using 6 different respiratory tracts) and 3D scintigraphic images using www.nature.com/scientificreports www.nature.com/scientificreports/ SPECT-CT (n = 1). Deposited fractions along nebulization system and within respiratory tracts were quantified and results are shown in Table 3 . The nebulized fraction corresponds to the proportion of the nominal dose that was efficiently nebulized (i.e. the initial activity injected into the nebulizer tank minus the remaining activity that remains after the nebulization process in the device). We observed on 2D scintigraphies ( Fig. 3 ) that radiolabeled aerosol was deposited within lungs with a more intense signal in the central regions of the lungs. Compared to data generated on the "healthy" ex vivo model 41 , aerosol penetration within the fibrotic lung was not as deep. Indeed, lung bases did not show the deposition of the radiolabeled aerosol. These two images showed that despites its limitations, this model presented regional aerosol deposition features associated with reduced lung compliance in regions treated to modify the mechanical properties of the parenchyma. However, it should be noted that the model only allowed to assess regional deposition of the aerosol. The absorption of the 99m Tc-DTPA and its diffusion in the different cell types composing parenchyma and mesenchyme of the respiratory tract could not be assessed. The development of a more complex model with perfusion and ventilation is currently under development and could furtherly answer to this limitation.
In a comparative manner, the study from Diaz et al. 29 focused on the delivery and the safety of inhaled interferon-γ. These experiments conducted on human were performed with a different nebulization technology (vibrating mesh nebulizer associated to inhalation-triggered nebulization), which generated an aerosol with larger particles while inhalations were performed with a deep and slow pattern. Therefore, comparison to this study should be carefully made. As seen in Table 4 , values from Diaz et al. are similar from those obtained with our model, when values are expressed as percentage of the nebulized dose, meaning that the regional aerosol deposition patterns are relatively close.
Overall, the presented results showed that aerosol deposition was mainly observed in the non-treated zones of the lungs. This feature is comparable to the one observed in patients. While this particular point seemed to be controversial for inhaled therapies in IPF, it could be a compelling point in favor of such therapies because the healthy regions of the parenchyma could already present molecular abnormalities associated with the proliferation of the fibrotic lesions 21 . Thus, even if it is important to develop medical devices that will allow higher depositions into the "fibrotic" regions, it remains important to also treat healthy regions of the lungs.
Reliability of the developed ex vivo fibrotic lungs compared to IPF-suffering patients in terms of aerosol regional deposition. Literature of such regional aerosol deposition studies in vivo is very scarce and do not allow quantitative comparison to assess deposition patterns. Thus, only qualitative comparisons between present experimental results and data found in literature could be made. However, qualitatively, by comparing our results to in vivo human data of IPF-suffering patients using similar nuclear imaging technique and administration procedure, we support the conclusion that the ex vivo fibrotic respiratory model is in good accordance with existing in vivo inputs of IPF-suffering patients 14, 20, 31, 44, 53, 54 .
This model raises some limitations, such as the supine position during nebulization process that decreases penetration of airborne particles such as nebulization. As previously observed on a panel of nebulizers with different size distribution 42 , the largest particles -with a MMAD of 2.8 µm -are mostly affected by impact while the smallest particles -with a MMAD of 0.23 µm -are mostly affected by turbulence-driven diffusion and would not be significantly impacted by the supine position. Only intermediate particles -with a MMAD of 0.55 µm -would be affected by the supine position, as the main mechanism driving their deposition is sedimentation. Hotspots are visible on planar scintigraphies due to parenchymal wound on the lungs, creating areas with less resistances and thus generating leakage of radioaerosol from the lungs toward inside this enclosure. However, a filter is placed in between the depression generator and the enclosure allowing to pick up aerosol. www.nature.com/scientificreports www.nature.com/scientificreports/ conclusion Despite the release of new treatments, idiopathic pulmonary fibrosis is a devastating pulmonary disease with a poor survival rate. Thus, new therapies are needed to manage this disease and improve patients' quality of life. Inhaled therapies could be promising treatments for IPF. Indeed, pulmonary delivery could lead to less adverse events for equal or better efficiency. However, due to ethical considerations, in vivo aerosol regional deposition studies with IPF-suffering patients are scarce. Since the pulmonary route remains challenging due to the decreased lung compliance, there is need for a useful tool for practical and inexpensive preclinical studies devoted to the local delivery of drugs to fibrotic lungs.
In this study, an ex vivo respiratory model of lung fibrosis was developed to assess aerosol regional deposition. This model consists in a 3D-printed adult upper airways replica connected to a porcine respiratory tract placed in a sealed enclosure. This experimental set-up allow to induce passive ventilation of lungs by inducing negative pressures within the enclosure (applying the same physical principle as intrapleural negative pressures observed in human breathing). Breathing pattern are easily and reproducibly controllable. Two RR were tested (i.e. 15 and 25 cycles/min) to experimentally assess 5 respiratory physiological measurements: MIF, TV, MV, R and C. Results obtained demonstrated that the breathing pattern of the IPF ex vivo model was varying in the same magnitude compared to in vivo data of IPF-suffering patients. Then, 81m Kr planar scintigraphies were used to assess homogeneity of gas-ventilation of the developed IPF ex vivo model. It proved to be qualitatively comparable to gas-ventilation observed in patients 15, 16, 20, 44, 52 . Besides, the homogeneity of the gas-ventilation leads to confirm the absence of any ventilation defect due to procedure used to decrease the pulmonary compliance of the IPF ex vivo model. Finally, the assessment of regional aerosol deposition was performed with 99m Tc-DTPA planar and 3D SPECT-CT images. Results obtained showed similar qualitative regional aerosol deposition compared to those found for in vivo human studies. Thus, we successfully developed an ex vivo respiratory model to simulate the alterations of pulmonary mechanics seen in lung fibrosis. However, the developed fibrotic lung model suffers from some limitations, such as the supine position, the lack of lung surfactant and the lack of blood perfusion. Moreover, patients suffering from IPF could overcome their failing pulmonary mechanical properties by increasing respiratory workload, while we only applied fixed negative pressures. These limitations are outweighed by advantages of this ex vivo model. First of all, this pathological respiratory model seems to be a good and relevant surrogate model to animal experiments for aerosol regional deposition studies, particularly compared to rodent models 55, 56 . Moreover, the ex vivo respiratory model is fitting the 3 R guidelines (Refine, Reduce and Replace). Secondly, this model is relatively cost-saving. Indeed, it does not need any animal husbandry nor sacrifice of research animals since we used porcine respiratory tracts, considered as waste, obtained from slaughterhouse which are considered as waste. Finally, the ex vivo model is easy to use and could be tuned as wanted. Hence, this work demonstrated that this original ex vivo respiratory model could reliably simulate IPF for aerosol regional deposition studies. Indeed, by proposing a model with low ethical restrictions and allowing alternative to animal and in vitro experiments, we hope that our work would support the preclinical development of inhaled therapies by providing more relevant and reliable data before clinical trials.
Materials and Methods

Materials.
A stereolithographied adult replica of upper airways, including larynx, was made by three-dimensional printing technology. This Ear-Nose-Throat (ENT) replica was obtained by reconstruction from CT scan images of a healthy subject. Data were obtained from Saint-Etienne teaching hospital. At arrival each patient received an information note explicitly stating that their date could be used for research purposes. Furthermore, written consent from patient is obtained in the Radiology ward. Lastly, use of such data was supervised by the Ethic Committee of Saint-Etienne hospital. It integrated laryngeal structures to mimic vocal folds resistance. This 3D-printed replica was anatomically, geometrically and aerodynamically validated using several techniques (endoscopy and CT scans) and was previously used for several nasal and pulmonary aerosol deposition studies 41, 42, 49, 57 . Porcine respiratory tracts were obtained just after slaughter (DespiViandes, La Talaudière France), satisfying all French sanitary controls, and were used within 24 hours or frozen at −20 °C depending on availability. At slaughtering time, swine were 6 months old, with 44% of female and 56% of male from three different species: large white, pietrain and landrace (with mainly large white). After removal of viscera, carcasses weighted 90 to 93 kg. Visual controls of wounds and sutures were achieved, and a bronchoscopy was performed to ensure the absence of significant obstruction of proximal bronchi. Lungs were placed in a sealed enclosure and ventilated using a depression generator (SuperDimension ® , Covidien, Dusseldorf, Germany). Figure S1 shows the set-up and is available in Supplementary information. The amplitude of depression during a respiratory cycle was −11 ± 2 kPa (equivalent −112 ± 20cmH 2 O) with a mean depression inside the enclosure of −9 kPa (−92cmH 2 O). These relatively high negative pressures were two time the expected values, according to West 50 . This is probably due to the lack of perfusion and the unknown status of lung surfactant. Thirty tracts were used for measurements of respiratory mechanics. Ex vivo lungs were not used during more than 8 hours. For all experiments, the model was set in supine position.
Development of physical methods to reduce lung compliance mimicking the mechanical behavior of a fibrotic lung.
To develop a method to mimic the reduced compliance of fibrotic lungs, 3 physical procedures were tested. For the first method, depending of the size of lungs, 3 to 5 g of ethyl cyanoacrylate glue (G) were applied on chosen areas of lungs and let out to polymerize at least 5 minutes to rigidify the external surface of the lung. The second method used hot steam jets (S), delivered by a steam cleaner, applied for 2 to 3 minutes on the surface of the lungs to induce heat denaturation of lung proteins. The third procedure was the combination of both glue and steam (GS), which were applied sequentially starting by S method with few minutes pause before using G method. During the application of the method, lungs were not inflated. For each method, 5 different incrementing stages were tested (n = 4): 0: Healthy stage (without treatment); and 4 stages where the physical methods were applied on 1: apices of upper lobes; 2: entire upper lobes; 3: entire upper lobes + bases of lower lobes; 4: whole lungs. For each stage, respiratory mechanics measurements described below were performed (see the section below). Endpoint of this development was to determine the best physical method (among glue, steam or glue + steam) inducing the highest decrease in lung compliance with the lowest modification of pulmonary resistances. Values were expressed as relative value of the healthy stage of the corresponding method (i.e. lungs without changes of compliance), for each physical method tested (i.e. glue, steam, or glue + steam). This expression of results allowed to compare only the impact of the physical methods on pulmonary compliance without potential biases due to the intrinsic variability of replicates.
Assessment of respiratory mechanics. The enclosure was instrumented thanks to Biopac ® system (Biopac, Goleta, CA, USA). Airflow at the ENT replica was followed with a pneumotachograph (TSD 117) while pressures in the enclosure were determined with a differential pressure transducer (TSD160D). Each component was connected to an amplifier (DA100C), connected to the acquisition hardware (MP160). Data were recorded for 4 minutes with AcqKnowledge ® 5.0 software. Then, eight experimental values were calculated from airflow and pressure: tidal volume (TV), minute ventilation (MV), respiratory rate (RR), inspiratory time (IT), expiratory time (ET), total time (TT), resistances (R) and compliance (C). Mean inspiratory flow (MIF) was manually calculated using Microsoft Office Excel 365 (Microsoft, Redmond, USA). Breathing cycles were identified using the software, tidal volume was obtained by integrating the airflow, resistances were calculated by the difference between pressure inside and outside the enclosure divided by the airflow, and finally the lung compliance was calculated by dividing the volume variation by the pressure variation. IT was fixed at 1.3 s, while ET was fixed at 2.6 s to obtain a RR of 15 cycles per minute, or IT at 0.8 s and ET at 1.6 s at to reach a RR of 25 cycles per minute. These breathing times led to a I:E ratio of 1:2. For each experiment, at least 40 breathing cycles were analyzed to calculate above-mentioned respiratory features and to determine mean ± standard deviation and confidence interval. We calculated the coefficient of TV, MV, R and C for each replicate to assess the reliability, with a threshold value was set at 15%. The coefficient of variation of TV, MV, R and C were calculated for the whole replication to assess the reproducibility, with a threshold value set at 30%. Ventilation and regional aerosol deposition. The evaluation of regional ventilation was performed on 12 respiratory tracts using 81m krypton ( 81m Kr) scintigraphies 58 . At each RR, an acquisition was realized with a naso-buccal mask (Ambu ® , Bordeaux, France) as interface. For the assessment of regional ventilation, two regions of interest (ROI) were drawn on each ventilation scintigraphy to identify left and right lung as well as central area and peripheral area 59 . The aim of these experiments was to assess the homogeneity of the regional gas-ventilation of the ex vivo fibrotic lung model and thus, to confirm the absence of any ventilation defect due to a too strong application of physical methods used to decrease the pulmonary compliance.
Deposition experiments were performed 99m technetium complexed with diethylene triamine pentaacetic acid ( 99m Tc-DTPA) as scintigraphic tracer. A 100MBq solution (3 mL) was placed in the Venticis II ® jet nebulizer (Curium, Paris, France). Generated aerosol (MMAD of 0.86) reached the adult replica of upper airways through the mean of a naso-buccal mask (Ambu ® , Bordeaux, France). Here, we aimed to quantitatively assess the aerosol regional deposition in the different components of the ex vivo model of pulmonary fibrosis (naso-buccal mask, head replica and lungs) to compare our results to: i) the previously developed healthy ex vivo respiratory model 41, 42 (to determine the impact of the alteration of lung compliance on the aerosol regional deposition) and ii) to in vivo human data from IPF-suffering patients 20, 31, 44 using similar nuclear imaging technique and administration procedure (to determine the reliability of the developed ex vivo fibrotic lung model compared to IPF patients in terms of aerosol regional deposition). Two-dimensional scintigraphies were conducted on six respiratory tracts. Experiments were performed with a variable angle dual detector Single Photon Emission Computed Tomography/Computed Tomography (SPECT/ CT, SYMBIA T2; Siemens, Knoxville, TN) with a matrix of 256 × 256. Low-energy, high-resolution collimator (FWHM 8.3 mm at 10 cm) -tested weekly for uniformity (UFOV 533 mm × 387 mm, CFOV 400 mm × 290 mm) -were used. The inhalation experiments needed to assess the initial radioactive dose in the nebulizer. The dose was calculated from the difference of activity between the full and empty syringe with 1-min anterior/posterior scintigraphic images. After inhalation of the aerosol (until atomization of the nebulizer), each component of the system was imaged with 3-min anterior/posterior exposition: nebulize (with dead volume), expiratory filter, ENT replica and respiratory tract. For each image, a ROI was drawn while 3 external ROIs were delimited to assess background. The count of each part was determined with corrections for background radiation, radioactivity decay and tissue attenuation (correction factor calculated for each component). Results were expressed in terms of the nominal dose of radioactivity loaded in the nebulizer.
After 2D acquisition, a SPECT and CT acquisitions could be carried out on the respiratory tract to cartography the anatomical deposition of the aerosol. This 3D SPECT acquisition the respiratory tract consisting of 64 (2 × 32) 30-sec images was coupled with a CT. Imaging parameters for this tomography were: 130 kV; 90mAs; 1.25 mm slice thickness; 0.9 mm increment; 1.6 mm pitch; rotation time of 1.5 s according to a previously developed protocol 42 . The associated hardware platform (Symbia net, Siemens) was used to review and to reconstruct the obtained images with the 3D Ordered-Subset Expectation Maximization (OSEM) algorithm. Default settings (8 subsets, 5 iterations) were used. Before reconstruction, the 3D Butterworth smoothing filter was applied with following parameters: cutoff: 0.45 cycles/cm; order. 5 The final images consisted of a 128 × 128 image matrix, with a 1.23 zoom and a pixel size of 3.9 mm. During reconstruction, scatter correction was used for SPECT images. It was also used to correct the attenuation for CT images. CT and SPECT images were associated into sagittal, coronal and transverse views. There, one respiratory tract was used for these 3D images.
